In conjunction with Cantor’s Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference, Pharmaceuticals & Biotech Analysts Chen, Kim and Brayer, along with Drs. Clewner Hafler and Jewelewicz, focus on the Ophthalmology Industry for 2023 at an Ophthalmology Physician Dinner to be held in Miami on December 8 at 6:30 pm hosted by Cantor Fitzgerald.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on APLS:
- Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
- Apellis Pops After FDA Accepts NDA Amendment For Drug
- Apellis Announces FDA Acceptance of NDA Amendment and New PDUFA Date of February 26, 2023 for Pegcetacoplan for Geographic Atrophy (GA)
- Apellis downgraded to Hold from Buy at Jefferies
